Financial insights of ORGN

MyFinsight

For the quarter ending 2025-09-30, ORGN made $4,657K in revenue. -$18,580K in net income. Net profit margin of -398.97%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenues	4,657	-	5,430	8,202
Cost of revenues (exclusive of depreciation and amortization shown separately below)	4,500	-	5,317	8,141
Research and development	3,328	-	3,301	5,127
General and administrative	10,717	-	10,111	9,347
Depreciation and amortization	2,836	-	2,714	2,822
Impairment of assets	210	-	16,610	15,170
Total operating expenses	17,091	-	32,736	32,466
Loss from operations	-16,934	-	-32,623	-32,405
Investment income	873	-	1,206	1,745
Interest expenses	27	-	48	86
Gain (loss) in fair value of derivatives	17	-	-38	-43
Gain (loss) in fair value of common stock warrants liability	163	-	2,778	-2,285
Gain (loss) in fair value of earnout liability	0	-	2,462	-2,941
Other expenses, net	-396	-	-119	-517
Total other income (expenses), net	630	-	6,241	-4,127
Loss before income tax provision	-16,304	-12,627	-26,382	-36,532
Income tax provision	78	120	59	231
Net loss	-16,382	-12,747	-26,441	-36,763
Unrealized gain on marketable securities	311	224	159	690
Foreign currency translation adjustment	-2,509	6,704	236	1,828
Total other comprehensive (loss) income	-2,198	6,928	395	2,518
Total comprehensive loss	-18,580	-5,819	-26,046	-34,245

Net loss per share, basic (in dollars per share)	-0.11	-0.09	-0.18	-0.26
Net loss per share, diluted (in dollars per share)	-0.11	-0.09	-0.18	-0.26
Weighted-average common shares outstanding, basic (in shares)	149,340,474	147,811,114	146,852,340	143,387,618
Weighted-average common shares outstanding, diluted (in shares)	149,340,474	147,811,114	146,852,340	143,387,618